Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
EverythingLubbock.com on MSN
KLBK Wednesday AM Weather Update (3/4/26)
Wednesday's highs will range from the middle 60s to the middle 70s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results